The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

External beam radiotherapy is associated with a 10% survival advantage in women with deeply myoinvasive, high-grade endometrial cancer only, but women at lower risk of recurrence do not benefit.

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 11.11%, which has investors questioning if this is right time ...

Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Zentalis Pharmaceuticals in a research note issued on Wednesday, February 5th. Leerink Partnrs ...

The rising consumption of processed foods raises serious health concerns, including increased risks of infertility and cancer ...

Healthcare: With ultra-processed food consumption surging by 13.7 per cent between 2011 and 2021, and rural India now ...

Equities research analysts at Wedbush boosted their FY2024 EPS estimates for shares of Zentalis Pharmaceuticals in a research note issued to investors on Wednesday, January 29th. Wedbush analyst R.

Abnormal Uterine Bleeding (AUB ... of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett’s oesophagus.

As the rates of obesity and severe obesity continue to increase, this technology will become increasingly vital to providing the highest quality care for the endometrial cancer population.

Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.